Formulation Strategies, Characterization, and In Vitro Evaluation of Lecithin-Based Nanoparticles for siRNA Delivery.

Journal of Drug Delivery
Sebastián Ezequiel PérezC Bregni

Abstract

The aim of the present work was to take advantage of lecithin's biocompatibility along with its physicochemical properties for the preparation of lecithin-based nanocarriers for small interfering RNA (siRNA) delivery. Water lecithin dispersions were prepared in different conditions, loaded with siRNA at different N/P ratios, and evaluated for loading capacity. The most appropriate ones were then assayed for cytotoxicity and characterized in terms of particle size distribution, zeta potential, and morphology. Results demonstrated that formulations prepared at pH 5.0 and 7.0 were able to load siRNA at broad N/P ratios, and cellular uptake assays showed an efficient delivery of oligos in MCF-7 human breast cancer cells; fluorescent-labeled dsRNA mainly located next to its target, near the nucleus of the cells. No signs of toxicity were observed for broad compositions of lecithin. The physicochemical characterization of the siRNA-loaded dispersions exhibited particles of nanometric sizes and pH-dependant shapes, which make them suitable for ex vivo and in vivo further evaluation.

References

Jul 11, 2000·Pharmaceutical Research·S DokkaY Rojanasakul
Mar 20, 2001·Journal of Colloid and Interface Science·Yao-Xiong HuangQi-Cai He
Jun 2, 2001·Human Gene Therapy·M Nishikawa, L Huang
Jul 12, 2002·Nature·Gregory J Hannon
Sep 25, 2002·International Journal of Pharmaceutics·Malgorzata SznitowskaStanislaw Janicki
Jul 2, 2003·Expert Opinion on Biological Therapy·Natasha J Caplen
Oct 3, 2003·Journal of Cellular Biochemistry·Ellen AckerstaffZaver M Bhujwalla
Nov 30, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jörg WeyermannAndreas Zimmer
Feb 28, 2006·International Journal of Pharmaceutics·Zhengrong CuiBrian R Sloat
Jul 13, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hongtao LvJie Yan
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jyotsnabaran HalderAnil K Sood
Jan 26, 2007·Pharmaceutical Research·Weijun Li, Francis C Szoka
Jun 2, 2007·Nature Reviews. Drug Discovery·Antonin de FougerollesJudy Lieberman
Dec 7, 2007·The Journal of Clinical Investigation·Alan M Gewirtz
Jan 8, 2008·Chemical & Pharmaceutical Bulletin·Malgorzata SznitowskaMarcin Placzek
Jan 10, 2008·Journal of the National Cancer Institute·Michael J GrayLee M Ellis
Mar 4, 2008·Journal of the National Cancer Institute·William M MerrittAnil K Sood
Nov 1, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·B GeusensM Van Gele
Dec 17, 2008·Current Cancer Drug Targets·Mónica Bañez-CoronelJuan Carlos Lacal
Jan 12, 2010·Journal of Internal Medicine·B OzpolatG Lopez-Berestein
Jan 19, 2010·International Journal of Pharmaceutics·S ZouJ G Hecker
Apr 1, 2010·Current Gene Therapy·Bharat KhuranaSuresh P Vyas
Mar 12, 2011·International Journal of Pharmaceutics·Jose Mario BarichelloHiroshi Kiwada

❮ Previous
Next ❯

Citations

Apr 29, 2014·BioMed Research International·Yamila B GándolaLorena Gonzalez
May 23, 2015·PLoS Neglected Tropical Diseases·Yashdeep PhanseLyric C Bartholomay
Aug 17, 2021·Frontiers in Bioengineering and Biotechnology·Ramzi Mukred SaeedMutasem Omar Taha

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
electrophoresis
Scanning Electron Microscopy
fluorescence microscopy

Software Mentioned

Silvander
GraphPad InStat

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Martin KöbelDavid G Huntsman
Journal of Internal Medicine
B OzpolatGabriel Lopez-Berestein
Journal of the Korean Association of Oral and Maxillofacial Surgeons
Insoo Kim
Advanced Drug Delivery Reviews
Bulent OzpolatGabriel Lopez-Berestein
© 2021 Meta ULC. All rights reserved